IP Verse

Aurobindo Pharma USA Inc. et al. vs Andrx Labs, LLC et al.

The detailed information for PTAB case with proceeding number IPR2017-01648 filed by Aurobindo Pharma USA Inc. et al. against Andrx Labs, LLC et al. on Jun 22, 2017. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2017-01648
Filing Date: Jun 22, 2017
Petitioner: Aurobindo Pharma USA Inc. et al.
Respondent: Andrx Labs, LLC et al.
Status: Final Written Decision
Respondent Application Number: 09705630
Respondent Tech Center: 1600
Respondent Patent Number: 6866866
Institution Decision Date: Dec 29, 2017
Termination Date: Dec 28, 2018

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Final Written Decision	Dec 28, 2018	PAPER	BOARD
Hearing Transcript	Oct 17, 2018	PAPER	BOARD
Panel Change Order	Sep 24, 2018	PAPER	BOARD
Exhibit 2012 - Jennifer Dressman Deposition Transcription	Sep 21, 2018	EXHIBIT	PATENT OWNER
PO's Updated Exhibit List	Sep 21, 2018	PAPER	PATENT OWNER
Order - 37 C.F.R. 42.70	Aug 10, 2018	PAPER	BOARD
Patent Owner's Request for Oral Argument	Aug 3, 2018	PAPER	PATENT OWNER
PETITIONER¿¿¿S REQUEST FOR ORAL ARGUMENT	Aug 2, 2018	PAPER	PETITIONER
Petitioner's Notice of Deposition	Jul 17, 2018	PAPER	PETITIONER
Petitioner's Reply to Patent Owner's Response	Jun 15, 2018	PAPER	PETITIONER
Basson et al., Pharmaceutical Research, Vol. 15	May 31, 2018	EXHIBIT	PATENT OWNER
Basson et al., Pharmaceutical Research, Vol. 13	May 31, 2018	EXHIBIT	PATENT OWNER
Vidon, et al., Diabetes Research and Clinical Practice	May 31, 2018	EXHIBIT	PATENT OWNER
Declaration of Jennifer Dressman, Ph.D.	May 31, 2018	EXHIBIT	PATENT OWNER
Deposition Transcript of Dr. Fatemeh Akhlaghi	May 31, 2018	EXHIBIT	PATENT OWNER
Patent Owner's Response	May 31, 2018	PAPER	PATENT OWNER
Patent Owners Revised Notice of Deposition of Dr. Fatemeh Akhlaghi	May 31, 2018	EXHIBIT	PATENT OWNER
FDA Guidance for Industry	May 31, 2018	EXHIBIT	PATENT OWNER
Why Cmax is a Continuous Variable and Tmax is a Categorical Variable	May 31, 2018	EXHIBIT	PATENT OWNER
Keraliya, et al., ISRN Pharmaceutics, Volume 2012	May 31, 2018	EXHIBIT	PATENT OWNER
Joint Stipulation to Modify Due Date 1	May 18, 2018	PAPER	PATENT OWNER
Granting Joint Motion to Limit the Petition	May 17, 2018	PAPER	BOARD
Joint Motion to Limit the Petition	May 16, 2018	PAPER	PETITIONER
Revised Notice of Deposition	May 15, 2018	PAPER	PATENT OWNER
Conduct of the Proceeding	May 9, 2018	PAPER	BOARD
Notice of Deposition	Apr 20, 2018	PAPER	PATENT OWNER
Joint Stipulation TO Modify Due Date 1 In Scheduling Order	Mar 16, 2018	PAPER	PATENT OWNER
Record of Initial Conference	Jan 30, 2018	PAPER	BOARD
PO Objection to Evidence	Jan 16, 2018	PAPER	PATENT OWNER
Scheduling Order	Jan 2, 2018	PAPER	BOARD
EXPUNGED	Jan 2, 2018	PAPER	BOARD
EXPUNGED	Jan 2, 2018	PAPER	BOARD
DECISION Institution of Inter Partes Review 37 C.F.R. sec 42.108	Dec 29, 2017	PAPER	BOARD
Patent Owner's Preliminary Response	Oct 11, 2017	PAPER	PATENT OWNER
Letter from FDA approving NDA 21-574	Oct 11, 2017	EXHIBIT	PATENT OWNER
Approved Fortamet Label	Oct 11, 2017	EXHIBIT	PATENT OWNER
NOTICE OF ACCEPTING CORRECTED PETITION	Jul 19, 2017	PAPER	BOARD
CERTIFICATE OF COMPLIANCE	Jul 18, 2017	PAPER	PETITIONER
CORRECTED PETITION FOR INTER PARTES REVIEW OF U.S. PATENT NO. 6,866,866	Jul 18, 2017	PAPER	PETITIONER
Notice of Accord Filing Date	Jul 12, 2017	PAPER	BOARD
Teva Power of Attorney	Jul 10, 2017	PAPER	PATENT OWNER
Andrx Power of Attorney	Jul 10, 2017	PAPER	PATENT OWNER
Shionogi Power of Attorney	Jul 10, 2017	PAPER	PATENT OWNER
PO Mandatory Notices	Jul 10, 2017	PAPER	PATENT OWNER
EX1002 WO1999047125A1	Jun 22, 2017	EXHIBIT	PETITIONER
EX1003 WO1999047128A1	Jun 22, 2017	EXHIBIT	PETITIONER
EX1004 US6099859	Jun 22, 2017	EXHIBIT	PETITIONER
EX1005 PFH '866 Patent	Jun 22, 2017	EXHIBIT	PETITIONER
EX1006 CFAC 12-1228 7-2-12	Jun 22, 2017	EXHIBIT	PETITIONER
EX1007 WO2000012097A1	Jun 22, 2017	EXHIBIT	PETITIONER
EX1009 Mylan Settlement	Jun 22, 2017	EXHIBIT	PETITIONER
EX1011 US6475521B1	Jun 22, 2017	EXHIBIT	PETITIONER
EX1012 Glucophage Label NDA 21202lbl	Jun 22, 2017	EXHIBIT	PETITIONER
EX1013 US5955106	Jun 22, 2017	EXHIBIT	PETITIONER
EX1001 US6866866B1	Jun 22, 2017	EXHIBIT	PETITIONER
EX1008 Lupin Settlement	Jun 22, 2017	EXHIBIT	PETITIONER
EX1010 Amendment	Jun 22, 2017	EXHIBIT	PETITIONER
EX1014 WO2000028989A1	Jun 22, 2017	EXHIBIT	PETITIONER
EX1017 US3845770	Jun 22, 2017	EXHIBIT	PETITIONER
EX1018 Chiao1995	Jun 22, 2017	EXHIBIT	PETITIONER
EX1015 US6284275	Jun 22, 2017	EXHIBIT	PETITIONER
EX1016 US6099862	Jun 22, 2017	EXHIBIT	PETITIONER
EX1019 Akhlaghi Declaration	Jun 22, 2017	EXHIBIT	PETITIONER
EX1020 Akhlaghi CV	Jun 22, 2017	EXHIBIT	PETITIONER
PETITION FOR INTER PARTES REVIEW OF U.S. PATENT NO. 6,866,866	Jun 22, 2017	PAPER	PETITIONER
Petitioner Aurobindo Pharma USA Inc's Power of Attorney	Jun 22, 2017	PAPER	PETITIONER